Gabapentin generic or brand name?

Gabapentin itself is the generic name of the drug. It was first approved by the FDA in 1993 for seizures and later for neuropathic pain. Since then, many manufacturers have produced it in generic form, and it’s sold under a handful of brand names—most commonly:

Why the difference matters

• Generic vs. brand: A generic drug contains the same active ingredient (gabapentin), has the same potency, and must meet the same bioequivalence standards as the brand version. The only differences are usually the inactive fillers, color, shape, or packaging.
• Price: Generics are typically 70‑90 % cheaper than brand names because the manufacturer doesn’t bear the original drug‑development cost.
• Insurance coverage: Many insurance plans cover the generic first and only pay for the brand if a doctor specifically prescribes it (sometimes called “brand‑specific” or “preferred” formulation).

When might you get a brand name instead of a generic?

• Special formulations: Some patients do better on an extended‑release version (e.g., Gralise) or a particular tablet size/color that isn’t available in generic form.
• Doctor’s preference or patient tolerance: Certain brands might use different excipients that some patients find easier to swallow or less likely to cause mild GI upset.
• Insurance mandates: Certain insurers may require a brand name if the generic isn’t covered or if the prescription is part of a special program (like a high‑dose protocol).

Bottom line

• Gabapentin is the generic name; any brand name (Neurontin, Horizont, Gralise, etc.) is just a marketed version of that same active ingredient.
• If cost is a concern, ask your pharmacist or doctor about generic options—they’re usually identical in efficacy and safety.
• If you’re already on a brand and it’s working well, switching to a generic is typically safe, but confirm with your healthcare provider first.